Westboro, MA, United States of America

Zheng Wang


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Zheng Wang in Anticancer Medicaments

Introduction

Zheng Wang is an accomplished inventor based in Westboro, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of self-emulsifying systems for anticancer medications. His innovative work aims to enhance the effectiveness of therapeutic agents in cancer treatment.

Latest Patents

Zheng Wang holds a patent for a self-emulsifying system containing an anticancer medicament. The patent describes a stabilized self-emulsifying system that includes a therapeutically effective amount of o-(chloroacetylcarbamoyl)fumigillol, a pharmaceutically acceptable carrier, and a stabilizing component. The carrier consists of an oily constituent and at least one surfactant, while the stabilizing component contains from about 1% to about 15% water relative to the weight of the self-emulsifying system, along with an acid, an adsorbent, or a complex-forming agent.

Career Highlights

Zheng Wang is currently employed at Abbott Laboratories Corporation, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in the development of new therapeutic systems.

Collaborations

Zheng Wang collaborates with Rong Ron Liu, contributing to advancements in their field through shared knowledge and expertise.

Conclusion

Zheng Wang's innovative work in developing self-emulsifying systems for anticancer medicaments showcases his commitment to improving cancer treatment options. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…